Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
Kastrup J, Jørgensen E, Rück A, Tägil K, Glogar D, Ruzyllo W, Bøtker HE, Dudek D, Drvota V, Hesse B, Thuesen L, Blomberg P, Gyöngyösi M, Sylvén C; Euroinject One Group. Kastrup J, et al. Among authors: sylven c. J Am Coll Cardiol. 2005 Apr 5;45(7):982-8. doi: 10.1016/j.jacc.2004.12.068. J Am Coll Cardiol. 2005. PMID: 15808751 Free article. Clinical Trial.
Therapeutic angiogenesis gains a leg to stand on.
Rück A, Sylvén C. Rück A, et al. Among authors: sylven c. Mol Ther. 2008 May;16(5):808-10. doi: 10.1038/mt.2008.65. Mol Ther. 2008. PMID: 18432271 Free article. No abstract available.
Randomized trials are also essential for device therapy.
Rück A, Sylvén C. Rück A, et al. Among authors: sylven c. J Intern Med. 2006 Sep;260(3):281; author reply 282-3. doi: 10.1111/j.1365-2796.2006.01681.x. J Intern Med. 2006. PMID: 16918826 Free article. No abstract available.
NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.
Gyöngyösi M, Khorsand A, Zamini S, Sperker W, Strehblow C, Kastrup J, Jorgensen E, Hesse B, Tägil K, Bøtker HE, Ruzyllo W, Teresiñska A, Dudek D, Hubalewska A, Rück A, Nielsen SS, Graf S, Mundigler G, Novak J, Sochor H, Maurer G, Glogar D, Sylven C. Gyöngyösi M, et al. Among authors: sylven c. Circulation. 2005 Aug 30;112(9 Suppl):I157-65. doi: 10.1161/01.CIRCULATIONAHA.105.525782. Circulation. 2005. PMID: 16159809 Clinical Trial.
Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy.
Sarkar N, Rück A, Källner G, Y-Hassan S, Blomberg P, Islam KB, van der Linden J, Lindblom D, Nygren AT, Lind B, Brodin LA, Drvota V, Sylvén C. Sarkar N, et al. Among authors: sylven c. J Intern Med. 2001 Nov;250(5):373-81. doi: 10.1046/j.1365-2796.2001.00905.x. J Intern Med. 2001. PMID: 11887971 Free article. Clinical Trial.
292 results